Haemagglutinin-strain A(H1N1)

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Afluria Tetra, Agriflu, FluLaval Tetra, Fluad, Fluad Pediatric, Fluviral, Fluzone High-dose, Fluzone Quadrivalent, Influvac, Influvac Tetra
Generic Name
Haemagglutinin-strain A(H1N1)
DrugBank Accession Number
DB15476
Background

Not Available

Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Inactivated
Synonyms
Not Available

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
ADIMFLUHaemagglutinin-strain A(H1N1) (15 mcg/0.5ml) + Haemagglutinin-strain A(H3N2) (15 mcg/0.5ml) + Influenza virus type B (Victoria) (15 mcg/0.5ml)บริษัท ไบโอเนท - เอเชีย จำกัด จำกัด2019-09-09Not applicableThailand flag
Afluria TetraHaemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Victoria) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Yamagata) (15 mcg / 0.5 mL)SuspensionIntramuscularSeqirus Pty Ltd2019-10-25Not applicableCanada flag
Afluria TetraHaemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Victoria) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Yamagata) (15 mcg / 0.5 mL)SuspensionIntramuscularSeqirus Pty Ltd2020-09-23Not applicableCanada flag
AgrifluHaemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain A(H3N2) (15 mcg) + Haemagglutinin-strain B (15 mcg)SuspensionIntramuscularSeqirus Uk Limited2010-10-042020-06-30Canada flag
AgrifluHaemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain A(H3N2) (15 mcg) + Haemagglutinin-strain B (15 mcg)SuspensionIntramuscularSeqirus Uk Limited2015-10-09Not applicableCanada flag
FluadHaemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (15 mcg / 0.5 mL)SuspensionIntramuscularSeqirus Uk Limited2011-09-10Not applicableCanada flag
Fluad PediatricHaemagglutinin-strain A(H1N1) (7.5 mcg / 0.25 mL) + Haemagglutinin-strain A(H3N2) (7.5 mcg / 0.25 mL) + Haemagglutinin-strain B (7.5 mcg / 0.25 mL)SuspensionIntramuscularSeqirus Uk Limited2015-11-05Not applicableCanada flag
Flucelvax QuadHaemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Victoria) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Yamagata) (15 mcg / 0.5 mL)SuspensionIntramuscularSeqirus Uk LimitedNot applicableNot applicableCanada flag
Flucelvax QuadHaemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Victoria) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Yamagata) (15 mcg / 0.5 mL)SuspensionIntramuscularSeqirus Uk Limited2020-09-21Not applicableCanada flag
Flulaval TetraHaemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Victoria) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Yamagata) (15 mcg / 0.5 mL)SuspensionIntramuscularID Biomedical Corporation of QuebecNot applicableNot applicableCanada flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available

References

General References
Not Available
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Active Not RecruitingBasic ScienceFlu caused by Influenza1
4CompletedBasic ScienceFlu caused by Influenza1
4CompletedBasic ScienceFlu caused by Influenza / Human Immunodeficiency Virus (HIV) Infections1
4CompletedBasic ScienceFlu caused by Influenza / Human Immunodeficiency Virus (HIV) Infections / Tuberculosis (TB)1
4CompletedHealth Services ResearchFlu caused by Influenza / Vaccination Site Reactions (HT)1
4CompletedOtherInfluenza (Healthy Volunteers)1
4CompletedPreventionFlu caused by Influenza15
4CompletedPreventionFlu caused by Influenza / H1N1 2009 Influenza1
4CompletedPreventionFlu caused by Influenza / Influenza Vaccine, Influenza1
4CompletedPreventionInfluenza Vaccine, Influenza2

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, suspensionIntramuscular
SuspensionIntramuscular
SuspensionIntramuscular; Subcutaneous
Injection, suspensionIntramuscular; Subcutaneous
SuspensionIntradermal
Injection
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on August 30, 2019 15:26 / Updated on June 12, 2020 16:53